Coates, L., Mease, P., Kronbergs, A., Helt, C., Sandoval, D., Park, S., . . . Deodhar, A. (2022). Efficacy and safety of ixekizumab in patients with active psoriatic arthritis with and without concomitant conventional disease-modifying antirheumatic drugs: SPIRIT-P1 and SPIRIT-P2 3-year results. Springer.
Citação do estilo Chicago (17ª ed.)Coates, L., P. Mease, A. Kronbergs, C. Helt, D. Sandoval, SY Park, B. Combe, P. Nash, e A. Deodhar. Efficacy and Safety of Ixekizumab in Patients with Active Psoriatic Arthritis with and Without Concomitant Conventional Disease-modifying Antirheumatic Drugs: SPIRIT-P1 and SPIRIT-P2 3-year Results. Springer, 2022.
Citação MLA (9ª ed.)Coates, L., et al. Efficacy and Safety of Ixekizumab in Patients with Active Psoriatic Arthritis with and Without Concomitant Conventional Disease-modifying Antirheumatic Drugs: SPIRIT-P1 and SPIRIT-P2 3-year Results. Springer, 2022.